Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Gains from Sales and Divestitures (2016 - 2021)

Orthofix Medical has reported Gains from Sales and Divestitures over the past 11 years, most recently at $86542.0 for Q4 2021.

  • For the quarter ending Q4 2021, Gains from Sales and Divestitures rose 16.89% year-over-year to $86542.0, compared with a TTM value of $86542.0 through Dec 2021, up 16.89%, and an annual FY2021 reading of $86542.0, up 16.89% over the prior year.
  • Gains from Sales and Divestitures came in at $86542.0 for Q4 2021, up from $74036.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $157807.0 in Q4 2017 to a low of $27982.0 in Q4 2018.
  • Median Gains from Sales and Divestitures over the past 5 years was $74036.0 (2020), compared with a mean of $78688.8.
  • The sharpest move saw Gains from Sales and Divestitures tumbled 82.27% in 2018, then surged 68.24% in 2019.
  • Over 5 years, Gains from Sales and Divestitures stood at $157807.0 in 2017, then tumbled by 82.27% to $27982.0 in 2018, then surged by 68.24% to $47077.0 in 2019, then surged by 57.27% to $74036.0 in 2020, then increased by 16.89% to $86542.0 in 2021.
  • Per Business Quant, the three most recent readings for OFIX's Gains from Sales and Divestitures are $86542.0 (Q4 2021), $74036.0 (Q4 2020), and $47077.0 (Q4 2019).